Figure 10. Relationships between prognostic-model-associated IRGs and clinical variables in the TCGA cohort. (A) PPY expression and pathological grade. (B) NAMPT expression and pathological grade. (C) ADIPOQ expression and pathological grade. (D) IL34 expression and pathological grade. (E) RAC3 expression and pathological grade. (F) TAP1 expression and pathological grade. (G) AHNAK expression and pathological grade. (H) PDGFRA expression and pathological grade. (I) Risk score and pathological grade. (J) AHNAK expression and clinical stage. (K) PDGFRA expression and clinical stage; (L) Risk score and clinical stage. (M) AHNAK expression and tumor stage. (N) PDGFRA expression and tumor stage. (O) Risk score and tumor stage.